Influence of Diagnosis Timing and Therapeutic Regimens of Allergic Rhinitis on Pregnancy Outcomes in Pregnant Patients
Year: 2026
Type: preprint
Study design: Observational Study
Abstract: Background and Objective Allergic rhinitis (AR) is a common allergic comorbidity in pregnant women. However, the correlation between AR onset/intervention timing and pregnancy outcomes remains insufficiently supported by large-sample evidence, and no unified standard has been established for the clinical application of different therapeutic regimens. This study aimed to investigate the influence of AR diagnosis timing and different therapeutic regimens on pregnancy outcomes in pregnant patients with AR, thereby providing evidence-based references for the standardized diagnosis and treatment of gestational AR. Methods This multicenter retrospective cohort study enrolled 5,083 pregnant patients with AR from two clinical centers: the Harvard University Partners Healthcare System (PARTNERS), and Longgang District Maternity & Child Healthcare Hospital of Shenzhen City in China. All participants completed full pregnancy follow-up between January 2016 and December 2024. The baseline data, AR diagnosis timing, therapeutic regimens and pregnancy outcome-related indicators of the patients were collected. The correlations of AR diagnosis timing (pre-pregnancy vs. intra-pregnancy) and four therapeutic regimens (intranasal corticosteroids, oral antihistamines, combination therapy, and no treatment) with pregnancy outcomes were analyzed. Results A total of 80.1% of patients were diagnosed with AR before pregnancy. The vaginal delivery rate in the pre-pregnancy diagnosis group was significantly higher than that in the intra-pregnancy diagnosis group (90.6% vs. 71.7%, P < 0.001), while the rates of cesarean section (9.4% vs. 28.3%, P < 0.001), low birth weight (4.0% vs. 6.9%, P = 0.002), neonatal complications (36.3% vs. 44.1%, P < 0.001), and abnormal 1-minute (7.7% vs. 16.3%, P < 0.001) and 5-minute Apgar scores < 7 (0.8% vs. 4.7%, P < 0.001) were significantly lower. No significant difference was observed in the preterm birth rate between the two groups (10.4% vs. 11.6%, P = 0.18). Significant differences in pregnancy outcomes were also found among therapeutic regimens (P < 0.05). Notably, the combination therapy group showed an unusually high vaginal delivery rate (98.2%) and elevated low birth weight rate (9.3%), which warrant careful data verification. Conclusion Pre-pregnancy diagnosis and standardized intervention for AR are associated with improved maternal and infant prognosis and reduced risk of adverse pregnancy outcomes. Treatment of gestational AR should follow the principle of individualization, with regimens selected based on patients' high-risk factors. Given the univariable nature of the regression analysis, these findings should be interpreted as observational associations rather than independent effects, and prospective studies with confounder adjustment are needed for confirmation.
Source: Research Square
Authors: tingyu luo(Writing – original draft, Writing – review & editing), Li Fang(Formal analysis, Writing – review & editing), Yao Yao(Data curation, Funding acquisition), Qiuling Shi(Funding acquisition, Methodology), Cheng Lei(Methodology), Jie Zhou(Formal analysis, Software), Lingling Xiong(Methodology, Writing – review & editing), Yousha Wang(Formal analysis, Writing – review & editing), Zhiling Zeng(Formal analysis, Writing – review & editing), Jinsong Li(Funding acquisition, Methodology), Fan Li(Data curation, Funding acquisition, Project administration, Writing – review & editing)
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7236632957
